Characteristics of heparin treatment
Parameter . | No. patients (%) . |
|---|---|
| Type of treatment | |
| Unfractionated heparin alone | 105 (58.0) |
| Low-molecular-weight heparin alone | 34 (18.8) |
| Unfractionated and low-molecular-weight heparin | 42 (23.2) |
| Dosage regimen of heparin therapy* | |
| Preventive dose | 81 (44.8) |
| Therapeutic dose | 115 (63.5) |
| Indication | |
| Cardiac and vascular diseases | 68 (37.6) |
| Treatment of venous thromboembolism | 41 (22.7) |
| Thromboprophylaxis in medical patients | 30 (16.6) |
| Thromboprophylaxis in orthopedic surgery | 13 (7.2) |
| Cardiovascular surgery | 6 (3.3) |
| Other | 23 (12.7) |
Parameter . | No. patients (%) . |
|---|---|
| Type of treatment | |
| Unfractionated heparin alone | 105 (58.0) |
| Low-molecular-weight heparin alone | 34 (18.8) |
| Unfractionated and low-molecular-weight heparin | 42 (23.2) |
| Dosage regimen of heparin therapy* | |
| Preventive dose | 81 (44.8) |
| Therapeutic dose | 115 (63.5) |
| Indication | |
| Cardiac and vascular diseases | 68 (37.6) |
| Treatment of venous thromboembolism | 41 (22.7) |
| Thromboprophylaxis in medical patients | 30 (16.6) |
| Thromboprophylaxis in orthopedic surgery | 13 (7.2) |
| Cardiovascular surgery | 6 (3.3) |
| Other | 23 (12.7) |
N = 181 patients
Fifteen patients received therapeutic and preventive doses of heparin